Angina Market Research Report - Forecast to 2027

Global Angina Market Research Report, by Type (Angina Pectoris), Diagnosis (Imaging, Stress Test), Treatment (Lifestyle, Medications, Angioplasty, and Stenting), End-Users (Hospital & Clinics, Diagnostic Centers, Academic Institutes)–Forecast Till 2027

ID: MRFR/Pharma/4293-HCR | February 2021 | Region: Global | 90 pages

Please note that the assessment period of the report has been updated from 2017-2023 to 2020-2027. Cordially fill the sample form for updated data.

Market Scenario


Angina is a significant symptom of the coronary artery disease and is described as squeezing, tightness, and heaviness of the chest. It is a type of chest pain, which is caused by a reduced flow of blood to the heart. Fatigue, shortness of breath, nausea, and sweating are some of the common symptoms of angina. The increasing prevalence of angina and the growing healthcare expenditure are the major drivers for the market growth. According to the report of the American Heart Association of 2016, the prevalence of angina in West Virginia was estimated to be around 6.2% and around 2.3% in Hawaii. Moreover, the growing geriatric and obese population followed by the increasing prevalence of coronary heart diseases provide favorable backgrounds for market growth. According to the World Health Organization, the total number of people who age 65 or more is projected to increase from 524 million in 2010 to approximately 1.5 billion by 2050. Additionally, according to a study published in the Annals of Translational Medicine Journal approximately 15.5 million people who aged 20 years or more within the U.S. suffered from the coronary heart disease, in 2016. However, factors such as low per capita healthcare expenditure and high cost for therapeutic procedures such as coronary bypass surgery are estimated to restraint the market growth during the forecast period. According to a study published by the Brazilian Journal of Cardiovascular Surgery in 2017, the average total cost for coronary bypass surgery was estimated to be ~USD 7,992.


Global Angina Market is expected to grow at an approximate CAGR of 5.1% during the forecast period.


Intended Audience



  • Pharmaceutical Companies

  • Biotechnological Institutes

  • Research and Development (R&D) Companies

  • Medical Research Laboratories

  • Market Research and Consulting Service Providers


Figure 1: - Global Angina Market Share, by Region


 Angina Market Share


Sources: WHO, American Heart Association, Annals of Translational Medicine, Brazilian Journal of Cardiovascular Surgery, Annual Reports, Press Release, White Paper, and Company Presentation


Segmentation


The global angina Market is segmented on the basis of type, diagnosis, treatment, and end-user.


On the basis of type, the market is segmented into angina pectoris, unstable angina, prinzmetal angina, and others. On the basis of diagnosis, the market is categorized into imaging, blood test, stress test, and others. The imaging segment is sub-segmented into electrocardiogram, chest X-ray, cardiac computerized tomography scan, cardiac MRI, and others. The blood test segment is sub-segmented into cholesterol test, low-density lipoprotein test, triglycerides test, and others. On the basis of treatment, the market is segmented into lifestyle changes, medications, angioplasty and stenting, coronary bypass surgery, and others. The medication segment is sub-segmented into aspirin, clot-preventing drugs, statins, ranolazine, and others. The clot-preventing drugs segment is further segmented into clopidogrel, prasugrel, and others. On the basis of end-user, the market is segmented into hospitals and clinics, diagnostic centers, academic institutes, and others.


Research Methodology


 Angina Market Methodology


Sources: WHO, American Heart Association, Annals of Translational Medicine, Brazilian Journal of Cardiovascular Surgery, Annual Reports, Press Release, White Paper, and Company Presentation


Regional Analysis


America dominates the global angina market owing to a well-developed healthcare sector, growing healthcare expenditure, and a huge patient population for coronary heart diseases. Moreover, global players such as Merck & Co., Inc. and Baxter within the region fuel the market growth.


Europe is the second largest market for angina. Factors such as availability of funds for research, growing number of obese and patient population, followed by the presence of developed economies such as France, Italy, and Germany within the region provide favorable backgrounds for regional market growth. According to the Eurostat in 2016, it was estimated that more than half of the adult population (51.6%) within the European Union was over-weight.


Asia Pacific is estimated to be the fastest growing region for the global angina market owing to the presence of developing economies such as India and China and a developing healthcare sector. Moreover, rising healthcare expenditure and favorable government policies are expected to boost the market growth during the forecast period.


The Middle East and Africa holds the least share in the global angina market, owing to the presence of poor economies, stringent government policies, and low per capita healthcare expenditure, especially within the African region. A majority of the market of the region is held by the Middle East owing to the increasing healthcare expenditure and presence of developed economies such as Saudi Arabia, Kuwait, and Qatar within the region.


Key players in the Global Angina Market


Anthera (U.S.), Taxus Cardium (U.S.), Astellas Pharma (Japan), Sanofi (France), Bayer AG (Germany), Merck & Co., Inc. (U.S.), Torrent Pharmaceuticals Limited (India), Huya Bioscience International (U.S.), Viromed Co. Ltd. (South Korea), Baxter (U.S.), and others.



Frequently Asked Questions (FAQ) :


Angina is a significant symptom of coronary artery disease and can be described as squeezing, tightness, and heaviness of the chest. It is a type of chest pain caused by a reduced flow of blood to the heart.

Global Angina Market is expected to exhibit a strong 5.1% CAGR over the forecast period till 2027.

The growing prevalence of cardiovascular diseases is the major driver for the global angina market.

The Americas dominate the Global Angina Market.

Leading players in the Angina Market include Bayer AG, Sanofi, and Astellas Pharma, among others.

TABLE OF CONTENT

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restrains

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Angina Market, by Type

6.1 Introduction

6.2 Angina Pectoris

Market Estimates & Forecast, 2020–2027

6.3 Unstable Angina

Market Estimates & Forecast, 2020–2027

6.4 Prinzmetal Angina

Market Estimates & Forecast, 2020–2027

6.5 Others

Chapter 7. Global Angina Market, by Diagnosis

7.1 Introduction

7.2 Imaging

Market Estimates & Forecast, 2020–2027

7.2.1 Electrocardiogram

7.2.2 Chest X-ray

7.2.3 Cardiac Computerized Tomography Scan

7.2.4 Cardiac MRI

7.2.5 Others

7.3 Blood Tests

Market Estimates & Forecast, 2020–2027

7.3.1 Cholesterol Test

7.3.2 Low-Density Lipoprotein Test

7.3.3 Triglycerides Test

7.3.4 Others

7.4 Stress Test

Market Estimates & Forecast, 2020–2027

7.5 Others

Chapter 8. Global Angina Market, by Treatment

8.1 Introduction

8.2 Lifestyle Changes

Market Estimates & Forecast, 2020–2027

8.3 Medications

Market Estimates & Forecast, 2020–2027

8.3.1 Aspirin

8.3.2 Clot-Preventing Drugs

Market Estimates & Forecast, 2020–2027

8.3.2.1 Clopidogrel

8.3.2.2 Prasugrel

8.3.2.3 Others

8.3.3 Statins

8.3.4 Ranolazine

8.3.5 Others

8.4 Angioplasty and Stenting

Market Estimates & Forecast, 2020–2027

8.5 Coronary Bypass Surgery

Market Estimates & Forecast, 2020–2027

8.6 Others

Chapter 9. Global Angina Market, by End-User

9.1 Introduction

9.2 Hospital & Clinics

Market Estimates & Forecast, 2020–2027

9.3 Diagnostic Centers

Market Estimates & Forecast, 2020–2027

9.4 Academic Institutes

Market Estimates & Forecast, 2020–2027

9.5 Others

Chapter 10. Global Angina Market, by Region

10.1 Introduction

10.2 America

10.2.1 North America

10.2.1.1 U.S.

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 U.K.

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 Republic of Korea

10.4.6 Rest of Asia Pacific

10.5 The Middle East & Africa

10.5.1 United Arab Emirates

10.5.2 Saudi Arabia

10.5.3 Oman

10.5.4 Kuwait

10.5.5 Qatar

10.5.6 Rest of the Middle East & Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

11.3.1 Key Developments

Chapter 12 Company Profiles

12.1 Anthera

12.1.1 Company Overview

12.1.2 Type Overview

12.1.3 Financials

12.2.4 Key Developments

12.1.5 SWOT Analysis

12.2 Taxus Cardium

12.2.1 Company Overview

12.2.2 Type Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Astellas Pharma

12.3.1 Company Overview

12.3.2 Type Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Sanofi

12.4.1 Company Overview

12.4.2 Type/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Bayer AG

12.5.1 Company Overview

12.5.2 Type Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Merck & Co., Inc.

12.6.1 Company Overview

12.6.2 Type Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Torrent Pharmaceuticals

12.7.1 Overview

12.7.2 Type Overview

12.7.3 Financials

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Huya Bioscience International

12.8.1 Overview

12.8.2 Type Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Viromed Co. Ltd.

12.9.1 Overview

12.9.2 Type Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Baxter

12.10.1 Overview

12.10.2 Type Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Others

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s View Point

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Prediction of Angina Market

Chapter 14 Appendix

LIST OF TABLES

Table 1 Angina Industry Synopsis, 2020–2027

Table 2 Global Angina Market Estimates & Forecast, 2020–2027, (USD Million)

Table 3 Global Angina Market, by Region, 2020–2027, (USD Million)

Table 4 Global Angina Market, by Type, 2020–2027, (USD Million)

Table 5 Global Angina Market, by Diagnosis, 2020–2027, (USD Million)

Table 6 Global Angina Market, by Treatment, 2020–2027, (USD Million)

Table 7 Global Angina Market, by End-User, 2020–2027, (USD Million

Table 8 North America Angina Market, by Type, 2020–2027, (USD Million)

Table 9 North America Angina, by Diagnosis, 2020–2027, (USD Million)

Table 10 North America Angina, by Treatment, 2020–2027, (USD Million)

Table 11 North America Angina, by End-User, 2020–2027, (USD Million)

Table 12 U.S. Angina Market, by Type, 2020–2027, (USD Million)

Table 13 U.S. Angina Market, by Diagnosis, 2020–2027, (USD Million)

Table 14 U.S. Angina Market, by Treatment, 2020–2027, (USD Million)

Table 15 U.S. Angina Market, by End-User, 2020–2027, (USD Million)

Table 16 Canada Angina Market, by Type, 2020–2027, (USD Million)

Table 17 Canada Angina Market, by Diagnosis, 2020–2027, (USD Million)

Table 18 Canada Angina Market, by Treatment, 2020–2027, (USD Million)

Table 19 Canada Angina Market, by End-User, 2020–2027, (USD Million)

Table 20 South America Angina Market, by Type, 2020–2027, (USD Million)

Table 21 South America Angina Market, by Diagnosis, 2020–2027, (USD Million)

Table 22 South America Angina Market, by Treatment, 2020–2027, (USD Million)

Table 23 South America Angina Market, by End-User, 2020–2027, (USD Million)

Table 24 Europe Angina Market, by Type, 2020–2027, (USD Million)

Table 25 Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)

Table 26 Europe Angina Market, by Treatment, 2020–2027, (USD Million)

Table 27 Europe Angina Market, by End-User, 2020–2027, (USD Million)

Table 28 Western Europe Angina Market, by Type, 2020–2027, (USD Million)

Table 29 Western Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)

Table 30 Western Europe Angina Market, by Treatment, 2020–2027, (USD Million)

Table 31 Western Europe Angina Market, by End-User, 2020–2027, (USD Million)

Table 32 Eastern Europe Angina Market, by Type, 2020–2027, (USD Million)

Table 33 Eastern Europe Angina Market, by Diagnosis, 2020–2027, (USD Million)

Table 34 Eastern Europe Angina Market, by Treatment, 2020–2027, (USD Million)

Table 35 Eastern Europe Angina Market, by End-User, 2020–2027, (USD Million)

Table 36 Asia Pacific Angina Market, by Type, 2020–2027, (USD Million)

Table 37 Asia Pacific Angina Market, by Diagnosis, 2020–2027, (USD Million)

Table 38 Asia Pacific Angina Market, by Treatment, 2020–2027, (USD Million)

Table 39 Asia Pacific Angina Market, by End-User, 2020–2027, (USD Million)

Table 40 The Middle East & Africa Angina Market, by Type, 2020–2027, (USD Million)

Table 41 The Middle East & Africa Angina Market, by Diagnosis, 2020–2027, (USD Million)

Table 42 The Middle East & Africa Angina Market, by Treatment, 2020–2027, (USD Million)

Table 43 The Middle East & Africa Angina Market, by End-User, 2020–2027, (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Angina Market

Figure 3 Market Dynamics for Global Angina Market

Figure 4 Global Angina Market Share, by Type 2020

Figure 5 Global Angina Market Share, by Diagnosis 2020

Figure 6 Global Angina Market Share, by Treatment, 2020

Figure 7 Global Angina Market Share, by End-User, 2020

Figure 8 Global Angina Market Share, by Region, 2020

Figure 9 North America Angina Market Share, by Country, 2020

Figure 10 Europe Angina Market Share, by Country, 2020

Figure 11 Asia Pacific Angina Market Share, by Country, 2020

Figure 12 The Middle East & Africa Angina Market Share, by Country, 2020

Figure 13 Global Angina Market: Company Share Analysis, 2020 (%)

Figure 14 Anthera: Key Financials

Figure 15 Anthera: Segmental Revenue

Figure 16 Anthera: Geographical Revenue

Figure 17 Taxus Cardium: Key Financials

Figure 18 Taxus Cardium: Segmental Revenue

Figure 19 Taxus Cardium: Geographical Revenue

Figure 20 Astellas Pharma: Key Financials

Figure 21 Astellas Pharma: Segmental Revenue

Figure 22 Astellas Pharma: Geographical Revenue

Figure 23 Sanofi: Key Financials

Figure 24 Sanofi: Segmental Revenue

Figure 25 Sanofi: Geographical Revenue

Figure 26 Bayer AG: Key Financials

Figure 27 Bayer AG: Segmental Revenue

Figure 28 Bayer AG: Geographical Revenue

Figure 29 Merck & Co., Inc.: Key Financials

Figure 30 Merck & Co., Inc.: Segmental Revenue

Figure 31 Merck & Co., Inc.: Geographical Revenue

Figure 32 Torrent Pharmaceuticals Limited: Key Financials

Figure 33 Torrent Pharmaceuticals Limited: Segmental Revenue

Figure 34 Torrent Pharmaceuticals Limited: Geographical Revenue

Figure 35 Huya Bioscience International: Key Financials

Figure 36 Huya Bioscience International: Segmental Revenue

Figure 37 Huya Bioscience International: Geographical Revenue

Figure 38 Viromed Co. Ltd.: Key Financials

Figure 39 Viromed Co. Ltd.: Segmental Revenue

Figure 40 Viromed Co. Ltd.: Geographical Revenue

Figure 41 Baxter: Key Financials

Figure 42 Baxter: Segmental Revenue

Figure 43 Baxter: Geographical Revenue